ψ-Bufarenogin, a lead compound of anti-cancer drug

被引：4
|
作者：
Ding, Jin [1 ]
Wang, Hongyang [1 ]
机构：
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Natl Ctr Liver Canc, Shanghai, Peoples R China
来源：
CELL CYCLE | 2015年 / 14卷 / 17期
关键词：
HEPATOCELLULAR-CARCINOMA;
D O I：
10.1080/15384101.2015.1071139
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2719 / 2720
页数：2
相关论文
共 50 条
  • [41] Indian anti-cancer drug trials halted
    Sharma, DC
    LANCET, 1999, 353 (9154): : 735 - 735
  • [42] Cannabidiol (CBD) as a Promising Anti-Cancer Drug
    Seltzer, Emily S.
    Watters, Andrea K.
    MacKenzie, Danny
    Granat, Lauren M.
    Zhang, Dong
    CANCERS, 2020, 12 (11) : 1 - 26
  • [43] Anti-Cancer Drug Screening with Microfluidic Technology
    Monjezi, Mojdeh
    Rismanian, Milad
    Jamaati, Hamidreza
    Kashaninejad, Navid
    APPLIED SCIENCES-BASEL, 2021, 11 (20):
  • [44] Bioinformatics Approaches for Anti-cancer Drug Discovery
    Li, Kening
    Du, Yuxin
    Li, Lu
    Wei, Dong-Qing
    CURRENT DRUG TARGETS, 2020, 21 (01) : 3 - 17
  • [45] PROTIDES AS A NEW ANTI-CANCER DRUG FAMILY
    McGuigan, Christopher
    Serpi, Michaela
    Slusarczyk, Magdalena
    Ferrari, Valentina
    Jimenez-Antunez, Carmen
    ANTICANCER RESEARCH, 2015, 35 (07) : 4312 - 4312
  • [46] Aspirin hailed as potential anti-cancer drug
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 45 (03) : 341 - 341
  • [47] Lipid nanoemulsions for anti-cancer drug therapy
    Souto, E. B.
    Nayak, A. P.
    Murthy, R. S. R.
    PHARMAZIE, 2011, 66 (07): : 473 - 478
  • [48] GPCRs: Emerging anti-cancer drug targets
    Gutierrez, Ainhoa Nieto
    McDonald, Patricia H.
    CELLULAR SIGNALLING, 2017, 41 : 65 - 74
  • [49] DNA anti-cancer drug design - Editorial
    Jing, NJ
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (22) : 2809 - 2809
  • [50] Correlation of anti-cancer drug structure to efficacy
    Turner, John
    Chalk, Stuart
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345